BPGAM
BSX icon

BTG Pactual Global Asset Management’s Boston Scientific BSX Stock Holding History

BTG Pactual Global Asset Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-35,200
Closed -$450K – 223
2014
Q2 		$450K Buy
+35,200
New +$458K 0.06% 168

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BTG Pactual Global Asset Management's BSX Position: Q3 2014 in Review

BTG Pactual Global Asset Management sold out of Boston Scientific (BSX) in Q3 2014, closing a stake of 35,200 shares — an estimated $450K sold.

BTG Pactual Global Asset Management first reported a position in BSX in Q2 2014 and held it in 1 quarter. The position peaked at $450K in Q2 2014. 437 funds tracked by Wall St. Rank hold BSX as of Q3 2014.

  • BTG Pactual Global Asset Management reported no remaining Boston Scientific position as of Q3 2014 after selling out during the quarter.
  • BTG Pactual Global Asset Management sold 35,200 Boston Scientific shares in Q3 2014, an estimated $450K.
  • BTG Pactual Global Asset Management first reported a position in Boston Scientific in Q2 2014 and held it in 1 quarter.
  • BTG Pactual Global Asset Management's Boston Scientific position peaked at $450K in Q2 2014.
  • 437 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2014.

Based on BTG Pactual Global Asset Management's 13F filing for Q3 2014, filed 12 Nov 2014.